World's Best Scientists 2026 revealed!
Award Badge
Immunology
Brazil
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 73 2163 1986 10 9 263 15418

Aldina Barral publications per year

The chart shows the history of publications by Aldina Barral between 1970 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Aldina Barral published across 56 years, from 1970 to 2025, averaging 5.9 papers a year. Output peaked at 21 publications in 2020. 11 of the 333 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1970 to 2025. Vertical axis: number of publications, 0 to 21. Peak 21 publications in 2020. 1970: 1 publication 1971: 0 publications 1972: 0 publications 1973: 0 publications 1974: 0 publications 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 0 publications 1979: 0 publications 1980: 0 publications 1981: 0 publications 1982: 0 publications 1983: 2 publications 1984: 3 publications 1985: 0 publications 1986: 6 publications 1987: 5 publications 1988: 3 publications 1989: 3 publications 1990: 3 publications 1991: 5 publications 1992: 7 publications 1993: 3 publications 1994: 2 publications 1995: 8 publications 1996: 5 publications 1997: 0 publications 1998: 5 publications 1999: 7 publications 2000: 5 publications 2001: 7 publications 2002: 6 publications 2003: 7 publications 2004: 6 publications 2005: 13 publications 2006: 17 publications 2007: 10 publications 2008: 10 publications 2009: 12 publications 2010: 20 publications 2011: 12 publications 2012: 15 publications 2013: 14 publications 2014: 11 publications 2015: 10 publications 2016: 8 publications 2017: 11 publications 2018: 14 publications 2019: 5 publications 2020: 21 publications 2021: 10 publications 2022: 4 publications 2023: 6 publications 2024: 4 publications 2025: 7 publications
1970 2025

333 publications in total across all disciplines

View publications per year as a table
Aldina Barral: publications per year, 1970 to 2025
Year Publications
1970 1
1971 0
1972 0
1973 0
1974 0
1975 0
1976 0
1977 0
1978 0
1979 0
1980 0
1981 0
1982 0
1983 2
1984 3
1985 0
1986 6
1987 5
1988 3
1989 3
1990 3
1991 5
1992 7
1993 3
1994 2
1995 8
1996 5
1997 0
1998 5
1999 7
2000 5
2001 7
2002 6
2003 7
2004 6
2005 13
2006 17
2007 10
2008 10
2009 12
2010 20
2011 12
2012 15
2013 14
2014 11
2015 10
2016 8
2017 11
2018 14
2019 5
2020 21
2021 10
2022 4
2023 6
2024 4
2025 7
Total 333
Download as CSV

Aldina Barral publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Aldina Barral sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 262–271 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 263 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116 263
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Aldina Barral D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Aldina Barral sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 72–73 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184 73
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Immunology in Brazil Leader Award
  • 2025 - Research.com Immunology in Brazil Leader Award
  • 2023 - Research.com Immunology in Brazil Leader Award
  • 2022 - Research.com Immunology in Brazil Leader Award

Overview

Aldina Barral is affiliated with the Oswaldo Cruz Foundation in Brazil and is active in the field of Medicine, with a particular focus on Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology, Neurology, and Molecular Biology. Their research spans multiple topics, including leishmaniasis studies, mosquito-borne diseases and control, Trypanosoma species research, viral infections and vectors, long-term effects of COVID-19, malaria research and control, and COVID-19 clinical research studies.

They have contributed to several scientific papers published in reputable journals, with notable recent examples including:

  • Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults (2024) in the New England Journal of Medicine
  • Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group (2023) in the Journal of Global Health
  • LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes (2021) in Diabetes
  • Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil (2024) in The Lancet Infectious Diseases
  • A clinical scoring system to predict long-term arthralgia in Chikungunya disease: A cohort study (2020) in PLoS neglected tropical diseases

Aldina Barral frequently collaborates with a group of co-authors, including Viviane Boaventura, Ricardo Khouri, Manoel Barral-Netto, Thiago Cerqueira-Silva, and Luciane Amorim Santos.

Their research has been published multiple times in venues such as PLoS neglected tropical diseases, Memórias do Instituto Oswaldo Cruz, Journal of Travel Medicine, Journal of Investigative Dermatology, and bioRxiv (Cold Spring Harbor Laboratory).

Best Publications

  • New Perspectives on a Subclinical Form of Visceral Leishmaniasis

    R. Badaro;T. C. Jones;E. M. Carvalho;D. Sampaio

  • Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

    Manoel Barral-Netto;Aldina Maria Prado Barral;Aldina Maria Prado Barral;Cari E. Brownell;Yasir A. W. Skeiky

  • Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease.

    Barral A;Pedral-Sampaio D;Grimaldi Júnior G;Momen H

  • Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.

    Roberto Badaro;Ernesto Falcoff;Fernando S. Badaro;Edgar M. Carvalho

  • Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance

    Bruno B. Andrade;Bruno B. Andrade;Antonio Reis-Filho;Antonio Reis-Filho;Sebastião M. Souza-Neto;Sebastião M. Souza-Neto;Jorge Clarêncio;Jorge Clarêncio

  • Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis

    Aldina Barral;Manoel Barral-Netto;Elenita C. Yong;Cari E. Brownell

  • CD4+CD25+ T Cells in Skin Lesions of Patients with Cutaneous Leishmaniasis Exhibit Phenotypic and Functional Characteristics of Natural Regulatory T Cells

    Ana P. Campanelli;Ana M. Roselino;Karen A. Cavassani;Marcelo S. F. Pereira

  • Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis.

    E.M. Carvalho;A. Barral;J.M.L. Costa;A. Bittencourt

  • Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection

    Fernanda O. Novais;Rômulo C. Santiago;André Báfica;Ricardo Khouri

  • Immunologic Markers of Clinical Evolution in Children Recently Infected with Leishmania donovani chagasi

    Edgar M. Carvalho;Aldina Barral;Diana Pedral-Sampaio;Manoel Barral-Netto

  • Human immune response to sand fly salivary gland antigens: a useful epidemiological marker?

    Aldina Barral;Eduardo Honda;Arlene Caldas;Jackson Costa

  • A simple method for human peripheral blood monocyte isolation.

    Marcos C de Almeida;Alan C Silva;Aldina Barral;Manoel Barral Netto

  • Balance of IL-10 and Interferon-γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis

    Arlene Caldas;Arlene Caldas;Cecília Favali;Dorlene Aquino;Dorlene Aquino;Vera Vinhas

  • Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines.

    Viviane S. Boaventura;Claire S. Santos;Cristina Ribeiro de Barros Cardoso;José de Andrade

  • Chemokines in host–parasite interactions in leishmaniasis

    Maria Jania Teixeira;Maria Jania Teixeira;Clarissa Romero Teixeira;Clarissa Romero Teixeira;Bruno Bezerril Andrade;Bruno Bezerril Andrade;Manoel Barral-Netto;Manoel Barral-Netto

  • Leishmanial infection: analysis of its first steps. A review

    M. C. de Almeida;V. Vilhena;A. Barral;Manoel Barral-Netto

  • Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses.

    Roberto Badaró;Steven G. Reed;Aldina Barral;Gloria Orge

  • Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.

    R. L. A. Bottrel;W. O. Dutra;F. A. Martins;B. Gontijo

  • Seroconversion against Lutzomyia longipalpis Saliva Concurrent with the Development of Anti–Leishmania chagasi Delayed-Type Hypersensitivity

    Regis B. Gomes;Cláudia Brodskyn;Cláudia Brodskyn;Camila I. de Oliveira;Jackson Costa

  • CD8(+) Granzyme B(+)-Mediated Tissue Injury vs. CD4(+)IFNγ(+)-Mediated Parasite Killing in Human Cutaneous Leishmaniasis

    Claire da Silva Santos;Claire da Silva Santos;Viviane Boaventura;Viviane Boaventura;Cristina Ribeiro Cardoso;Natalia Tavares;Natalia Tavares

  • Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.

    Edgar M. Carvalho;Olivia Bacellar;Aldina Barral;Roberto Badaro

Frequent Co-Authors

Manoel Barral-Netto
Manoel Barral-Netto Oswaldo Cruz Foundation
Cláudia Brodskyn
Cláudia Brodskyn Oswaldo Cruz Foundation
Edgar M. Carvalho
Edgar M. Carvalho Federal University of Bahia
Bruno B. Andrade
Bruno B. Andrade Oswaldo Cruz Foundation
Olli Ruuskanen
Olli Ruuskanen Turku University Hospital
Roberto Badaró
Roberto Badaró Federal University of Bahia
Manuel Soto
Manuel Soto Autonomous University of Madrid
Helena Käyhty
Helena Käyhty Finnish Institute for Health and Welfare (THL)
Jesus G. Valenzuela
Jesus G. Valenzuela National Institutes of Health
João S. Silva
João S. Silva Universidade de São Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring allied fields such as psychiatric and acute care nursing can broaden your career opportunities. Many students pursue advanced nursing degrees online to specialize in areas that intersect with immunological health, such as mental health nursing. Programs like the best psychiatric mental health nurse practitioner programs online combine rigorous academics with strong clinical placement, offering flexible pathways for working professionals.

Cost is often a key consideration. If affordability is a priority, the cheapest online pmhnp certificate programs provide budget-friendly options without compromising quality. These programs can help prepare you for roles that involve managing immune-related psychological conditions.

Understanding salary prospects is also important when planning your education and career. Reviewing resources like the dnp salary by state can help you gauge financial outcomes in different regions.

If you're already a Family Nurse Practitioner considering a shift, pathways like the fnp to acute care certification allow specialization in acute care settings, often involving complex immune system disorders. This transition offers further specialization aligned with immunological expertise and patient care.

Best Scientists Citing Aldina Barral

Trending Scientists

Recently Published Articles